Skip to content
Curcumin C3 Reduct®
  • Curcumin C3 Reduct®
    • Introduction
    • Chemistry
    • Pharmacokinetics
    • Advantages
  • Research
    • Pre-clinical
    • Clinical
    • Safety Studies
    • References
  • IP Rights
    • Patents
  • About Sabinsa
    • Newsroom
      • Press Release
      • Media Coverage
      • White Papers
      • Newsletters
      • Articles
      • Milestones
      • Ads
  • Contact Us

Sabinsa Signs Memorandum of Understanding with Japan External Trade Organization at Summit With Prime Ministers of India and Japan

Sabinsa Japan Corporation, a division of the Sami-Sabinsa Group, has signed a Memorandum of Understanding (MOU) with the Japan External Trade Organization (JETRO) to support Sabinsa’s expansion in Japan.

The MOU was signed during the 13th India-Japan Annual Summit, held between the Honorable Prime Minister of India Mr. Narendra Modi and the Honorable Prime Minister of Japan Mr. Shinzo Abe, on October 29, 2018 in Tokyo.

“As we continue our global expansion, we deeply appreciate the support of the Government of India and the trade development programs of the countries in which we do business, such as JETRO,” said Sabinsa founder Dr. Muhammed Majeed. “Although we have had an office in Japan for some time, the support of the Government of Japan as we continue our investment in that country will allow us to more quickly make our products to enhance human health available on a wider scale to the people of Japan.”

Back

About Sabinsa

Sabinsa is a manufacturer, supplier and marketer of herbal extracts, cosmeceuticals, minerals, dietary supplements and specialty fine chemicals for the nutritional, cosmetic, pharmaceutical and food industries.

Read More..

Headquarters

Sabinsa Corporation

20 Lake Drive 

East Windsor

NJ 08520, USA

 

Tel : +1 732 777 1111

Fax: +1 732 777 1443

info@sabinsa.com

Global Contact List

USA India
Utah, USA Japan
Australia Poland
Brasil Korea
Canada South Africa
China Vietnam
Germany  

Contact us

    © 2025 Sabinsa. All Rights Reserved | Privacy Policy | Sitemap | Terms of Use | Disclaimer

    ×

    Disclaimer

    US-FDA: This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Usage disclaimer: The information pertaining to any marketing materials by Sabinsa, is for general purposes only. Users are urged to check the validity of patents if any, on any Sabinsa items for their intended use.

    EFSA: This statement has not been evaluated by the EFSA. This product is not intended to diagnose, treat, cure, or prevent any disease.

    Australia: Please note as an ingredient supplier the information contained in this website is for marketers of finished products formulations and is not intended as consumer advice. Marketers should ensure finished products are lawful and comply with the regulations of the countries in which these items are sold. Every care has been taken to ensure the accuracy of the information provided at the time of publication.